科研製薬の株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2018/09/28 | 6,050 | 6,100 | 6,010 | 6,040 | +40 | +0.7% | 65,300 |
| 2018/09/27 | 6,040 | 6,120 | 5,980 | 6,000 | -70 | -1.2% | 99,900 |
| 2018/09/26 | 6,020 | 6,070 | 5,960 | 6,070 | -10 | -0.2% | 85,300 |
| 2018/09/25 | 5,950 | 6,090 | 5,950 | 6,080 | +150 | +2.5% | 128,300 |
| 2018/09/21 | 5,830 | 5,990 | 5,740 | 5,930 | +140 | +2.4% | 173,700 |
| 2018/09/20 | 5,850 | 5,870 | 5,770 | 5,790 | -80 | -1.4% | 91,100 |
| 2018/09/19 | 5,840 | 5,890 | 5,800 | 5,870 | +60 | +1% | 92,300 |
| 2018/09/18 | 5,680 | 5,830 | 5,670 | 5,810 | +130 | +2.3% | 110,800 |
| 2018/09/14 | 5,670 | 5,730 | 5,650 | 5,680 | +40 | +0.7% | 117,700 |
| 2018/09/13 | 5,630 | 5,730 | 5,620 | 5,640 | +40 | +0.7% | 73,800 |
| 2018/09/12 | 5,570 | 5,650 | 5,540 | 5,600 | -20 | -0.4% | 105,400 |
| 2018/09/11 | 5,570 | 5,650 | 5,570 | 5,620 | -10 | -0.2% | 89,400 |
| 2018/09/10 | 5,620 | 5,680 | 5,590 | 5,630 | +40 | +0.7% | 96,600 |
| 2018/09/07 | 5,550 | 5,680 | 5,540 | 5,590 | ±0 | ±0% | 93,300 |
| 2018/09/06 | 5,660 | 5,670 | 5,580 | 5,590 | -110 | -1.9% | 95,400 |
| 2018/09/05 | 5,670 | 5,750 | 5,650 | 5,700 | +30 | +0.5% | 79,100 |
| 2018/09/04 | 5,660 | 5,700 | 5,620 | 5,670 | +10 | +0.2% | 55,800 |
| 2018/09/03 | 5,640 | 5,670 | 5,610 | 5,660 | -50 | -0.9% | 51,100 |
| 2018/08/31 | 5,600 | 5,740 | 5,590 | 5,710 | +80 | +1.4% | 146,700 |
| 2018/08/30 | 5,670 | 5,670 | 5,600 | 5,630 | +40 | +0.7% | 99,100 |
| 2018/08/29 | 5,580 | 5,610 | 5,540 | 5,590 | +60 | +1.1% | 75,800 |
| 2018/08/28 | 5,600 | 5,600 | 5,510 | 5,530 | -40 | -0.7% | 67,400 |
| 2018/08/27 | 5,530 | 5,600 | 5,500 | 5,570 | +70 | +1.3% | 109,900 |
| 2018/08/24 | 5,530 | 5,530 | 5,480 | 5,500 | +10 | +0.2% | 42,700 |
| 2018/08/23 | 5,380 | 5,500 | 5,380 | 5,490 | +60 | +1.1% | 126,100 |
| 2018/08/22 | 5,370 | 5,470 | 5,360 | 5,430 | +80 | +1.5% | 95,000 |
| 2018/08/21 | 5,300 | 5,390 | 5,300 | 5,350 | ±0 | ±0% | 79,900 |
| 2018/08/20 | 5,390 | 5,390 | 5,300 | 5,350 | +20 | +0.4% | 82,900 |
| 2018/08/17 | 5,300 | 5,340 | 5,260 | 5,330 | ±0 | ±0% | 99,800 |
| 2018/08/16 | 5,430 | 5,440 | 5,310 | 5,330 | -130 | -2.4% | 173,500 |
| 2018/08/15 | 5,510 | 5,510 | 5,440 | 5,460 | -70 | -1.3% | 84,600 |
| 2018/08/14 | 5,510 | 5,580 | 5,490 | 5,530 | +70 | +1.3% | 92,200 |
| 2018/08/13 | 5,450 | 5,480 | 5,430 | 5,460 | ±0 | ±0% | 74,000 |
| 2018/08/10 | 5,450 | 5,490 | 5,430 | 5,460 | -10 | -0.2% | 80,400 |
| 2018/08/09 | 5,480 | 5,500 | 5,460 | 5,470 | -40 | -0.7% | 59,500 |
| 2018/08/08 | 5,520 | 5,560 | 5,470 | 5,510 | -50 | -0.9% | 90,400 |
| 2018/08/07 | 5,530 | 5,580 | 5,480 | 5,560 | -20 | -0.4% | 63,500 |
| 2018/08/06 | 5,600 | 5,620 | 5,540 | 5,580 | +40 | +0.7% | 122,300 |
| 2018/08/03 | 5,580 | 5,580 | 5,490 | 5,540 | -20 | -0.4% | 89,100 |
| 2018/08/02 | 5,590 | 5,630 | 5,500 | 5,560 | -30 | -0.5% | 202,300 |
| 2018/08/01 | 5,760 | 5,870 | 5,540 | 5,590 | -200 | -3.5% | 284,700 |
| 2018/07/31 | 5,740 | 5,810 | 5,710 | 5,790 | +20 | +0.3% | 128,700 |
| 2018/07/30 | 5,740 | 5,810 | 5,710 | 5,770 | -60 | -1% | 114,400 |
| 2018/07/27 | 5,820 | 5,850 | 5,760 | 5,830 | +20 | +0.3% | 72,500 |
| 2018/07/26 | 5,740 | 5,830 | 5,740 | 5,810 | +90 | +1.6% | 75,300 |
| 2018/07/25 | 5,810 | 5,840 | 5,710 | 5,720 | -70 | -1.2% | 87,200 |
| 2018/07/24 | 5,870 | 5,880 | 5,790 | 5,790 | ±0 | ±0% | 82,100 |
| 2018/07/23 | 5,770 | 5,830 | 5,770 | 5,790 | +50 | +0.9% | 80,100 |
| 2018/07/20 | 5,750 | 5,760 | 5,680 | 5,740 | +10 | +0.2% | 124,000 |
| 2018/07/19 | 5,850 | 5,880 | 5,710 | 5,730 | -20 | -0.3% | 95,000 |
1601～
1650
件表示中 / 3686件
類似銘柄と比較する
現在ご覧いただいている「科研薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 科研薬 | 413,300円 | +30.5% | +111.0% | 4.60% | 11.65倍 | 1.01倍 |
|
旧理研グループの名門。導入の関節機能改善剤、自社創製の爪白癬症薬の２本柱。後発品も展開 |
| 日本新薬 | 361,300円 | +7.9% | +8.9% | 3.43% | 7.73倍 | 1.04倍 |
|
医家向け医薬品主体、自社創薬は泌尿器科、血液内科、難病・希少疾患に集中。機能食品も育成 |
| ペプチド | 188,000円 | +5.0% | +1.5% | 0.00% | 16.14倍 | 4.29倍 |
|
東大発のペプチド創薬ベンチャーの雄。海外製薬大手との提携多数。買収で放射性医薬品に参入 |
| キッセイ薬 | 384,500円 | +14.5% | -2.3% | 2.34% | 14.07倍 | 0.75倍 |
|
医薬品中堅。泌尿器、腎・透析、未充足医療が重点領域。主軸特許切れ、新しい柱育成。海外は導出 |
| サンバイオ | 208,800円 | - | - | 0.00% | - | 96.71倍 |
|
脳疾患向け再生細胞薬の開発・製造・販売目指すバイオベンチャー。米国で創業し日本に逆上陸 |
市場注目の銘柄
チャート関連のコラム
